Frontline plc.
FRO – 2024 Annual General Meeting
FRO – 2024 Annual General Meeting
Frontline plc (the “Company”) advises that the 2024 Annual General Meeting of the Shareholders of the Company was held on 12 December 2024 at 09:00 a.m. at Metis Tower, 28th October Avenue and Iakovou Tombazi Street, 4th floor, 3107 Limassol, Cyprus. The audited consolidated financial statements for the Company for the year ended 31 December 2023 were presented to the Meeting.
In addition, the following resolutions were passed:
- To re-elect John Fredriksen as a Director of the Company.
- To re-elect James O’Shaughnessy as a Director of the Company.
- To re-elect Ola Lorentzon as a Director of the Company.
- To re-elect Cato Stonex as a Director of the Company.
- To re-elect Steen Jakobsen as a Director of the Company.
- To elect Ørjan Svanevik as a Director of the Company.
- To elect Dr. Maria Papakokkinou as a Director of the Company.
- To re-appoint PricewaterhouseCoopers of Limassol, Cyprus as auditors and to authorise the Directors to determine their remuneration.
- To approve the remuneration of the Company’s Board of Directors of a total amount of fees not to exceed USD 600,000 for the year ended December 31, 2024.
- To approve with effect from 12:00 p.m. (Cyprus time) on 12th December, 2024 (the “Effective Date”) and for a period of twelve (12) calendar months from the Effective Date the exclusion of the shareholders’ right of pre-emption with respect to any offer by the Company to the public against cash consideration, as may be decided by the Board of Directors from time to time, of a maximum of 377,377,111 ordinary shares of nominal value USD 1 each ranking pari passu with the existing ordinary shares of the Company at a subscription price which shall be determined by the Board of Directors not lower than USD 1 per share.
- To approve with effect from 12:00 pm (Cyprus time) on 12th December, 2024 (the “Effective Date”) and for a period of twelve (12) calendar months from the Effective Date the exclusion of the shareholders’ right of pre-emption with respect to any offer by the Company to the public for cash consideration as may be decided by the Board of Directors from time to time, of a maximum of 377,377,111 debentures or other securities convertible into ordinary shares of nominal value USD 1 each ranking pari passu with the existing ordinary shares of the Company or options or other securities carrying the right to subscribe for ordinary shares of the Company of nominal value USD 1 each ranking pari passu with the existing ordinary shares of the Company at a subscription price which shall be determined by the Board of Directors not lower than USD 1 per security.
- To approve on an advisory vote basis the Company’s Remuneration Report for the year ended December 31st, 2023 pursuant to the provisions of the Encouragement of Long-Term Shareholders Engagement Law 111(I)/2021.
12 December 2024
The Board of Directors
Frontline plc
Limassol, Cyprus
This information is subject to the disclosure requirements pursuant to Section 5-12 the Norwegian Securities Trading Act.
Subscribe to releases from Globenewswire
Subscribe to all the latest releases from Globenewswire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Globenewswire
Siili Solutions Oyj9.7.2025 17:30:00 CEST | Press release
Siili Solutions Plc: Share Repurchase 9.7.2025
TCM Group A/S9.7.2025 17:05:00 CEST | Pressemeddelelse
TCM Group A/S: Storaktionærmeddelelse
TCM Group A/S9.7.2025 17:05:00 CEST | Press release
TCM Group A/S: Major shareholder announcement
Bavarian Nordic A/S9.7.2025 16:46:37 CEST | Pressemeddelelse
Bavarian Nordic modtager ny ordre på koppe-/mpoxvacciner fra europæisk land
Bavarian Nordic A/S9.7.2025 16:46:37 CEST | Press release
Bavarian Nordic Enters New Smallpox/Mpox Vaccine Supply Contract with European Country
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom